Literature DB >> 30042641

Anxiety, Mood, and Personality Disorders in Patients with Benign Paroxysmal Positional Vertigo.

Hasan Hüseyin Kozak1, Mehmet Akif Dündar2, Ali Ulvi Uca1, Faruk Uğuz3, Keziban Turgut3, Mustafa Altaş1, Gonca Tekin3, Suhayb Kuria Aziz2.   

Abstract

INTRODUCTION: This study presents the current prevalence of anxiety, mood, and personality disorders as well as factors associated with the existence of psychiatric disorders in patients with benign paroxysmal positional vertigo (BPPV).
METHODS: The study sample comprised 46 patients with BPPV and 74 control subjects. Anxiety and mood disorders were ascertained via the Structured Clinical Interview for the Diagnostic and Statistical Manual (DSM) of Mental Disorders, Fourth Edition/Clinical Version. Personality disorders were diagnosed via the Structured Clinical Interview for DSM, Revised Third Edition, Personality Disorders.
RESULTS: Of the 46 patients, 18 (39.1%) had at least one mood or anxiety disorder and 13 (28.3%) had at least one personality disorder. The most common Axis I and Axis II disorders in the patient group were major depression in 8 (17.4%) and obsessive-compulsive personality disorder in 10 (21.7%) patients, respectively. It was found that major depression (p=0.021), generalized anxiety disorder (p=0.026) and obsessive- compulsive personality disorder (p=0.001) were more prevalent in the BPPV group compared with the control group.
CONCLUSION: Results suggest that psychiatric disturbances should be carefully checked in patients with BPPV due to the relatively high rate of comorbidity.

Entities:  

Keywords:  Benign paroxysmal positional vertigo; anxiety; depression; personality disorders; psychiatric disorders

Year:  2018        PMID: 30042641      PMCID: PMC6045803          DOI: 10.5152/npa.2016.18143

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  33 in total

1.  Psychological distress and disability in patients with vertigo.

Authors:  D Monzani; L Casolari; G Guidetti; M Rigatelli
Journal:  J Psychosom Res       Date:  2001-06       Impact factor: 3.006

Review 2.  Chronic dizziness: the interface between psychiatry and neuro-otology.

Authors:  Jeffrey P Staab
Journal:  Curr Opin Neurol       Date:  2006-02       Impact factor: 5.710

3.  Epidemiology of benign paroxysmal positional vertigo: a population based study.

Authors:  M von Brevern; A Radtke; F Lezius; M Feldmann; T Ziese; T Lempert; H Neuhauser
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-29       Impact factor: 10.154

4.  Population prevalence of psychiatric disorders in Chile: 6-month and 1-month rates.

Authors:  Benjamin Vicente; Robert Kohn; Pedro Rioseco; Sandra Saldivia; Christine Baker; Silverio Torres
Journal:  Br J Psychiatry       Date:  2004-04       Impact factor: 9.319

5.  Anxiety disorders and other psychiatric subgroups in patients complaining of dizziness.

Authors:  A Eckhardt-Henn; P Breuer; C Thomalske; S O Hoffmann; H C Hopf
Journal:  J Anxiety Disord       Date:  2003

6.  Cognitions associated with anxiety in Ménière's disease.

Authors:  Sarah E Kirby; Lucy Yardley
Journal:  J Psychosom Res       Date:  2008-11-22       Impact factor: 3.006

7.  The prevalence of psychological disturbance in neurotology outpatients.

Authors:  L McKenna; R S Hallam; R Hinchcliffe
Journal:  Clin Otolaryngol Allied Sci       Date:  1991-10

8.  A prospective study on the course of anxiety after vestibular neuronitis.

Authors:  Frank Godemann; Michael Linden; Peter Neu; Esther Heipp; Peggy Dörr
Journal:  J Psychosom Res       Date:  2004-03       Impact factor: 3.006

9.  Psychiatric and otologic diagnoses in patients complaining of dizziness.

Authors:  M Sullivan; M R Clark; W J Katon; M Fischl; J Russo; R A Dobie; R Voorhees
Journal:  Arch Intern Med       Date:  1993-06-28

10.  Screening for depression among neuro-otology patients with and without identifiable vestibular lesions.

Authors:  E A Grunfeld; M A Gresty; A M Bronstein; M Jahanshahi
Journal:  Int J Audiol       Date:  2003-04       Impact factor: 2.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.